Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pembrolizumab plus epacadostat Phase 3 trial (Japan)
jRCT2080223828Phase 3Completed
- Start
- Feb 2018
- Modality
- Immune Checkpoint Inhibitors → Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes, Small Molecules
01
Overview
Phase 3 trial of pembrolizumab and epacadostat. Started Feb 2018; status: completed.
02
Drugs
pembrolizumabepacadostat
Beyond the preview
Go deeper on jRCT2080223828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223828.